Benitec Biopharma Inc. Balance Sheet
BNTC|2 years of annual SEC 10-K data (FY2020-FY2021)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
Benitec Biopharma Inc. had $21M in total assets and $10M in shareholders' equity as of FY2021.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 | FY2020 |
|---|---|---|
| Cash & Equivalents | $9.8M | $15.7M |
| Current Assets | $20.6M | $10.8M |
| PP&E (Net) | $375.0K | $374.0K |
| Total Assets | $21.4M | $11.6M |
| Current Liabilities | $1.4M | $1.1M |
| Shareholders' Equity | $10.2M | $16.6M |